Skip to content
10-Q

Quarterly Report

Valion Bio, Inc. VBIO

0001437749-25-035216

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 1.77M sh
Capex Q3 2025 · Sep 30, 2025 $13K
Capex Q3 2025 · Sep 30, 2024 $0
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$4.71M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$4.36M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $3.45M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2M
Stockholders Equity Q3 2025 · Sep 30, 2025 $5.59M
Stockholders Equity Q3 2025 · Jun 30, 2025 $3.69M
Stockholders Equity Q3 2025 · Mar 31, 2025 $3.04M
Stockholders Equity Q3 2025 · Dec 31, 2024 $2.54M
Stockholders Equity Q3 2025 · Sep 30, 2024 $2.83M
Stockholders Equity Q3 2025 · Jun 30, 2024 $4.19M
Stockholders Equity Q3 2025 · Mar 31, 2024 $2.15M
Stockholders Equity Q3 2025 · Dec 31, 2023 $3.58M
Current Liabilities Q3 2025 · Sep 30, 2025 $638K
Current Liabilities Q3 2025 · Dec 31, 2024 $272K
Total Liabilities Q3 2025 · Sep 30, 2025 $638K
Total Liabilities Q3 2025 · Dec 31, 2024 $272K
Current Assets Q3 2025 · Sep 30, 2025 $3.74M
Current Assets Q3 2025 · Dec 31, 2024 $2.64M
Total Assets Q3 2025 · Sep 30, 2025 $6.23M
Total Assets Q3 2025 · Dec 31, 2024 $2.81M
Eps Basic Q3 2025 · Sep 30, 2025 −$1.97
Eps Basic Q3 2025 · Sep 30, 2025 −$6.49
Eps Basic restated Q3 2025 · Sep 30, 2024 −$3.93
Eps Basic restated Q3 2025 · Sep 30, 2024 −$18.22
Rd Expense Q3 2025 · Sep 30, 2025 $858K
Rd Expense Q3 2025 · Sep 30, 2025 $1.85M
Rd Expense Q3 2025 · Sep 30, 2024 $422K
Rd Expense Q3 2025 · Sep 30, 2024 $980K
Net Income Q3 2025 · Sep 30, 2025 −$2.6M
Net Income Q3 2025 · Sep 30, 2025 −$6.03M
Net Income Q3 2025 · Jun 30, 2025 −$1.93M
Net Income Q3 2025 · Mar 31, 2025 −$1.5M
Net Income Q3 2025 · Sep 30, 2024 −$1.43M
Net Income Q3 2025 · Sep 30, 2024 −$4.18M
Net Income Q3 2025 · Jun 30, 2024 −$1.27M
Net Income Q3 2025 · Mar 31, 2024 −$1.48M
Operating Income Q3 2025 · Sep 30, 2025 −$2.48M
Operating Income Q3 2025 · Sep 30, 2025 −$5.92M
Operating Income Q3 2025 · Sep 30, 2024 −$1.43M
Operating Income restated Q3 2025 · Sep 30, 2024 −$4.18M
Gross Profit Q3 2025 · Sep 30, 2025 −$145K
Gross Profit Q3 2025 · Sep 30, 2025 −$41K
Gross Profit Q3 2025 · Sep 30, 2024 $44K
Gross Profit Q3 2025 · Sep 30, 2024 $241K
Revenue Q3 2025 · Sep 30, 2025 $146K
Revenue Q3 2025 · Sep 30, 2025 $302K
Revenue Q3 2025 · Sep 30, 2024 $126K
Revenue Q3 2025 · Sep 30, 2024 $600K